Overview
Barbara Gulanski is an Endocrinologist in New Haven, Connecticut. Dr. Gulanski is rated as an Experienced provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Juvenile Primary Osteoporosis, Osteoporosis, Postmenopausal Osteoporosis, Ovarian Overproduction of Androgens, and Hormone Replacement Therapy (HRT).
His clinical research consists of co-authoring 15 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Hormone Replacement Therapy (HRT).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Additional Areas of Focus
Dr. Gulanski has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Montefiore At 1250 Waters Place
Jill P. Crandall, MD, is Professor and Jacob A. and Jeanne E. Barkey Chair in Medicine and Chief, Division of Endocrinology at Montefiore Einstein. Her clinical focus is on the treatment of types 1 and type 2 diabetes as well as related metabolic disorders. Dr. Crandall is rated as an Advanced provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Low Testosterone, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Type 1 Diabetes (T1D), and Hormone Replacement Therapy (HRT).
UConn John Dempsey Hospital
Francesco Celi is an Endocrinologist in Farmington, Connecticut. Dr. Celi is rated as an Advanced provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Hypothyroidism, Thyroid Cancer, Papillary Thyroid Cancer, Hormone Replacement Therapy (HRT), and Thyroidectomy.
Pediatric Endocrinology
Laurie E. Cohen, MD, is Chief, Pediatric Endocrinology & Diabetes and Professor, Pediatrics at Montefiore Einstein. An expert in growth disorders and short stature in children, Dr. Cohen also specializes in endocrine issues experienced by childhood cancer survivors, such as growth hormone deficiency and decreased fertility. Dr. Cohen is rated as an Advanced provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Idiopathic Short Stature (ISS), Short Stature (Growth Disorders), Sheehan Syndrome, Pediatric Growth Hormone Deficiency, and Hormone Replacement Therapy (HRT).
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Juvenile Primary OsteoporosisDr. Gulanski isAdvanced. Learn about Juvenile Primary Osteoporosis.
- Experienced
- Hormone Replacement Therapy (HRT)Dr. Gulanski isExperienced. Learn about Hormone Replacement Therapy (HRT).
- HyperparathyroidismDr. Gulanski isExperienced. Learn about Hyperparathyroidism.
- HypoparathyroidismDr. Gulanski isExperienced. Learn about Hypoparathyroidism.
- Low Blood SugarDr. Gulanski isExperienced. Learn about Low Blood Sugar.
- Maturity Onset Diabetes of the YoungDr. Gulanski isExperienced. Learn about Maturity Onset Diabetes of the Young.
- MelorheostosisDr. Gulanski isExperienced. Learn about Melorheostosis.